Track Selecta Biosciences's operating income ($-7.3M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowAs of Sep 30, 2026
Trailing 12 months ending Sep 30, 2026
Selecta Biosciences (SELB) currently reports a operating income of $-7.3M as of September 2026. That compares with $28M in the prior-year period — down 126.0% year over year. Use the charts on this page to explore Selecta Biosciences's operating income history and peer comparisons.
Selecta Biosciences's operating income decreased from $28M to $-7.3M — a 126.0% year-over-year decrease (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Selecta Biosciences reported $-7.3M in operating income as of September 2026. That compares with $28M in the prior-year period — down 126.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current operating income of $-7.3M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Selecta Biosciences, and consider following SELB for alerts when major investors trade the stock.
Selecta Biosciences is classified in the Healthcare sector. On operating income, it currently shows $-7.3M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SELB with unrelated industries.